Surgery Partners PE Ratio 2013-2024 | SGRY
Current and historical p/e ratio for Surgery Partners (SGRY) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Surgery Partners PE ratio as of June 21, 2024 is 27.55.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Surgery Partners PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-06-21 | 24.49 | 0.00 | |
| 2024-03-31 | 29.83 | $-0.00 | 0.00 |
| 2023-12-31 | 31.99 | $-0.10 | 0.00 |
| 2023-09-30 | 29.25 | $-0.32 | 0.00 |
| 2023-06-30 | 44.99 | $-0.56 | 0.00 |
| 2023-03-31 | 34.47 | $-0.92 | 0.00 |
| 2022-12-31 | 27.86 | $-0.58 | 0.00 |
| 2022-09-30 | 23.40 | $-0.35 | 0.00 |
| 2022-06-30 | 28.92 | $-0.35 | 0.00 |
| 2022-03-31 | 55.05 | $-0.53 | 0.00 |
| 2021-12-31 | 53.41 | $-1.24 | 0.00 |
| 2021-09-30 | 42.34 | $-1.34 | 0.00 |
| 2021-06-30 | 66.62 | $-2.52 | 0.00 |
| 2021-03-31 | 44.26 | $-2.99 | 0.00 |
| 2020-12-31 | 29.01 | $-3.18 | 0.00 |
| 2020-09-30 | 21.90 | $-3.65 | 0.00 |
| 2020-06-30 | 11.57 | $-2.70 | 0.00 |
| 2020-03-31 | 6.53 | $-2.43 | 0.00 |
| 2019-12-31 | 15.66 | $-2.27 | 0.00 |
| 2019-09-30 | 7.39 | $-4.95 | 0.00 |
| 2019-06-30 | 8.14 | $-5.05 | 0.00 |
| 2019-03-31 | 11.28 | $-5.03 | 0.00 |
| 2018-12-31 | 9.79 | $-4.96 | 0.00 |
| 2018-09-30 | 16.50 | $-2.54 | 0.00 |
| 2018-06-30 | 14.90 | $-2.59 | 0.00 |
| 2018-03-31 | 17.15 | $-2.11 | 0.00 |
| 2017-12-31 | 12.10 | $-1.64 | 0.00 |
| 2017-09-30 | 10.35 | $-0.46 | 0.00 |
| 2017-06-30 | 22.75 | $0.15 | 151.67 |
| 2017-03-31 | 19.50 | $0.28 | 69.64 |
| 2016-12-31 | 15.85 | $0.19 | 83.42 |
| 2016-09-30 | 20.24 | $0.19 | 106.53 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.011B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.295B | 15.60 |
| Cencora (COR) | United States | $47.007B | 18.33 |
| ICON (ICLR) | Ireland | $26.068B | 24.61 |
| DiDi Global (DIDIY) | China | $21.483B | 0.00 |
| Avantor (AVTR) | United States | $14.638B | 21.55 |
| CochLear (CHEOY) | Australia | $14.016B | 0.00 |
| Revvity (RVTY) | United States | $13.265B | 23.27 |
| Natera (NTRA) | United States | $13.164B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.413B | 40.84 |
| Viatris (VTRS) | United States | $12.216B | 3.65 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.939B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.798B | 20.67 |
| Solventum (SOLV) | United States | $9.292B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.560B | 0.00 |
| HealthEquity (HQY) | United States | $7.157B | 45.96 |
| Bausch + Lomb (BLCO) | Canada | $5.309B | 21.25 |
| Organon (OGN) | United States | $5.259B | 4.99 |
| Doximity (DOCS) | United States | $5.034B | 35.26 |
| PACS (PACS) | United States | $4.404B | 0.00 |
| Life Times (LTH) | United States | $3.653B | 38.27 |
| Sotera Health (SHC) | United States | $3.278B | 16.08 |
| GoodRx Holdings (GDRX) | United States | $2.927B | 111.43 |
| Agilon Health (AGL) | United States | $2.612B | 0.00 |
| Progyny (PGNY) | United States | $2.413B | 41.54 |
| NovoCure (NVCR) | Jersey | $2.063B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.019B | 8.00 |
| Premier (PINC) | United States | $1.914B | 8.19 |
| BrightSpring Health Services (BTSG) | United States | $1.785B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.637B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.356B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.176B | 0.00 | |
| CareDx (CDNA) | United States | $0.728B | 0.00 |
| Embecta (EMBC) | United States | $0.719B | 4.89 |
| GeneDx Holdings (WGS) | United States | $0.703B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.649B | 6.88 |
| InnovAge Holding (INNV) | United States | $0.619B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.594B | 0.00 |
| Enhabit (EHAB) | United States | $0.442B | 44.05 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.432B | 0.00 |
| ModivCare (MODV) | United States | $0.370B | 6.93 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.313B | 17.11 |
| LifeMD (LFMD) | United States | $0.300B | 0.00 |
| Sharecare (SHCR) | United States | $0.281B | 0.00 |
| MultiPlan (MPLN) | United States | $0.247B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.219B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| So-Young (SY) | China | $0.111B | 53.55 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.045B | 0.00 |
| NeueHealth (NEUE) | United States | $0.043B | 5.83 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.031B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.024B | 0.00 |
| OncoCyte (OCX) | United States | $0.024B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.001B | 0.00 |